Ardent Health Partners (ARDT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Ardent Health Partners

    NYSE: ARDT · Real-Time Price · USD
    14.02
    0.83 (6.29%)
    At close: Oct 03, 2025, 3:59 PM
    13.95
    -0.46%
    Pre-market: Oct 06, 2025, 06:46 AM EDT

    Ardent Health Partners Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
    Revenue
    		 1.65B 1.5B 1.61B 1.45B 1.47B 1.44B 1.35B 1.38B 1.37B 1.32B
    Cost of Revenue
    		 671.7M 657.65M 264.09M 813.77M 259.39M 257.78M 249.69M 35.49M 34.67M 34.7M
    Gross Profit
    		 973.58M 839.58M 1.34B 636.04M 1.21B 1.4B 1.1B 1.38B 1.33B 1.28B
    Operating Income
    		 142.07M 68.74M 384.64M 337.86M -157.41M 78.75M 11.32M 66.96M 86.51M 54.15M
    Interest Income
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 121.99M 74.2M 167.25M 57.07M 82.18M 56.56M 942K 45.97M 67.82M 29M
    Net Income
    		 72.95M 41.38M 114.2M 26.32M 42.77M 27.03M -7.76M 20.84M 33.08M 4.14M
    Selling & General & Admin
    		 297.01M 280.86M 1.01B 274.22M 957.91M 948.26M 939.33M 903.04M 894.78M 885.37M
    Research & Development
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Expenses
    		 554.58M 484.53M 179.22M 304.75M 411.02M 157.18M 145.69M 474.69M 473.95M 342.76M
    Operating Expenses
    		 851.59M 765.38M 1.18B 578.98M 1.37B 1.11B 1.09B 1.38B 1.37B 1.23B
    Interest Expense
    		 14.73M 14.18M 13.53M 14.63M 18.16M 17.04M 9.57M 19.04M 18.69M 18.12M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 1.52B 1.42B 1.45B 1.38B 1.63B 1.36B 1.33B 1.38B 1.29B 1.26B
    Income Tax Expense
    		 26.29M 15.23M 26.36M 11.06M 15.22M 10.71M -3.81M 7.26M 12.11M 5.22M
    Shares Outstanding (Basic)
    		 140.22M 140.06M 142.75M 137.11M 142.76M 143.26M 142.11M 140.96M 142.76M 143.26M
    Shares Outstanding (Diluted)
    		 141.11M 140.7M 132.75M 137.54M 142.76M 143.26M 142.11M 140.96M 142.76M 143.26M
    EPS (Basic)
    		 0.52 0.30 0.80 0.19 0.30 0.19 -0.05 0.15 0.23 0.03
    EPS (Diluted)
    		 0.52 0.29 0.86 0.19 0.30 0.19 -0.05 0.15 0.23 0.03
    EBITDA
    		 181.94M 121.7M 203.33M 108.47M 136.66M 107.46M 46.49M 100.5M 121.18M 81.82M
    EBIT
    		 142.63M 85.5M 165.48M 71.7M 100.34M 72.11M 10.51M 65.01M 86.51M 47.12M
    Depreciation & Amortization
    		 39.31M 36.2M 37.85M 36.77M 36.31M 35.35M 35.98M 35.49M 34.67M 34.7M

    Add to Watchlist